Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 SEK | +6.23% | +21.35% | +13.68% |
25/04 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
21/03 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Sales 2024 * | 26.75M 2.45M 204M | Sales 2025 * | 52.18M 4.77M 398M | Capitalization | 363M 33.18M 2.77B |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.78M -732M | Net income 2025 * | -93M -8.5M -709M | EV / Sales 2024 * | 10 x |
Net cash position 2024 * | 94.7M 8.66M 722M | Net cash position 2025 * | 58M 5.3M 442M | EV / Sales 2025 * | 5.85 x |
P/E ratio 2024 * |
-3.58
x | P/E ratio 2025 * |
-2.56
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB
1 day | +6.23% | ||
1 week | +21.35% | ||
Current month | +17.93% | ||
1 month | +16.86% | ||
3 months | -10.74% | ||
6 months | -53.65% | ||
Current year | +13.68% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 24/22/24 |
Director of Finance/CFO | 50 | 12/19/12 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 03/18/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 03/18/03 |
Director/Board Member | 68 | 03/18/03 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 26/20/26 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.24 | +6.23% | 440,998 |
25/24/25 | 3.05 | +10.51% | 355,255 |
24/24/24 | 2.76 | 0.00% | 126,115 |
23/24/23 | 2.76 | -3.16% | 431,759 |
22/24/22 | 2.85 | +6.74% | 243,245 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:59 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 33.11M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MVIR B Stock